Trial · NCT03151993
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Haematuria | Renal and urinary disorders | Recombinant Staphylokinase | 7 | 168 | 7 |
| other | Haematuria | Renal and urinary disorders | Actilyse | 8 | 168 | 8 |
| serious | Cerebral oedema | Nervous system disorders | Recombinant Staphylokinase | 7 | 168 | 7 |
| serious | Cerebral oedema | Nervous system disorders | Actilyse | 14 | 168 | 14 |
| serious | Symptomatic intracranial haemorrhage | Nervous system disorders | Recombinant Staphylokinase | 5 | 168 | 5 |
| serious | Symptomatic intracranial haemorrhage | Nervous system disorders | Actilyse | 13 | 168 | 13 |
| serious | Surgery | Nervous system disorders | Recombinant Staphylokinase | 5 | 168 | 5 |
| serious | Surgery | Nervous system disorders | Actilyse | 3 | 168 | 3 |
| serious | Neurosurgery | Nervous system disorders | Recombinant Staphylokinase | 2 | 168 | 2 |
| serious | Neurosurgery | Nervous system disorders | Actilyse | 1 | 168 | 1 |
| serious | Acute myocardial infarction | Cardiac disorders | Recombinant Staphylokinase | 1 | 168 | 1 |
| serious | Acute myocardial infarction | Cardiac disorders | Actilyse | 1 | 168 | 1 |
| serious | Pulmonary thromboembolism | Blood and lymphatic system disorders | Recombinant Staphylokinase | 1 | 168 | 1 |
| serious | Pulmonary thromboembolism | Blood and lymphatic system disorders | Actilyse | 3 | 168 | 3 |
| serious | New acute ischaemic stroke | Nervous system disorders | Recombinant Staphylokinase | 1 | 168 | 1 |
| serious | New acute ischaemic stroke | Nervous system disorders | Actilyse | 0 | 168 | 0 |
| serious | Gastric ulcer | Gastrointestinal disorders | Recombinant Staphylokinase | 0 | 168 | 0 |
| serious | Gastric ulcer | Gastrointestinal disorders | Actilyse | 2 | 168 | 2 |
| serious | Takotsubo cardiomyopathy | Cardiac disorders | Recombinant Staphylokinase | 0 | 168 | 0 |
| serious | Takotsubo cardiomyopathy | Cardiac disorders | Actilyse | 1 | 168 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03151993/events